Uxenta Overdosage

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Overdosage

Febuxostat (Uxenta) were studied in healthy patients in doses up to 300 mg daily for seven days without evidence of dose-limiting toxicities. No overdose of Febuxostat (Uxenta) were reported in clinical studies. Patients should be managed by symptomatic and supportive care should there be an overdose.

febuxostat

Manufacturer:

Globela Pharma

Distributor:

Oxpharm

Marketer:

AMB HK